Pluristem Therapeutics Has Been Selected to Present at The Israeli Presidential Conference 2009: Facing Tomorrow, Based on the Company’s Proprietary Technology and the Potential to Shape The Future of the Stem Cell Industry

HAIFA, Israel--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced it has been selected as one of the Israeli innovators in the stem cell field to present at The Israeli Presidential Conference 2009: Facing Tomorrow – Tomorrow's Industries exhibition, on Oct. 20-22, at the Congress Center of the Jerusalem International Convention Center in Jerusalem, Israel. During the conference, members of Pluristem’s management team will be available to discuss the company’s innovative stem cell technology and its leading position in Israel’s biotechnology industry.
MORE ON THIS TOPIC